Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

491
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
491

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sensitivity of ultra-widefield fundus photography for retinal break localisation in primary rhegmatogenous retinal detachment.

Eye (London, England)·2026
Same author

Design and Preclinical Validation of an Eyeglass-Coupled Perilimbal Antenna for Retinal Prostheses With a Biocompatible Graft Technique.

Translational vision science & technology·2026
Same author

Chronic central serous chorioretinopathy with and without myopia: clinical features and response to half-dose photodynamic therapy.

Photodiagnosis and photodynamic therapy·2026
Same author

From enrichment to interpretation: PS4-driven reclassification in Taiwanese inherited retinal degeneration.

Human genomics·2026
Same author

Diabetic macular atrophy, a pilot exploration of its characteristics, progression, and visual implications.

Eye (London, England)·2026
Same author

Bortezomib Inhibits Cellular Proliferation and Inflammation in a Mouse Model of Proliferative Vitreoretinopathy.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026

Related Experiment Video

Updated: Jul 26, 2025

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
08:10

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

Published on: January 25, 2019

7.9K

Refining vitrectomy for proliferative diabetic retinopathy.

San-Ni Chen1,2, Shih-Jen Chen3,4, Tsung-Tien Wu4,5

  • 1Department of Ophthalmology, China Medical University Hospital, Taichung, Taiwan.

Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie
|June 14, 2023
PubMed
Summary
This summary is machine-generated.

Pars plana vitrectomy (PPV) advances enable broader treatment for severe diabetic retinopathy. New technologies enhance surgical approaches for complex diabetic eye complications, particularly in Asian patients.

Keywords:
Diabetic retinopathyFibrovascular proliferationPars plana vitrectomyRetinal detachmentVitreous hemorrhage

More Related Videos

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

3.8K
Subretinal Implantation of RPE on a Carrier in Minipigs: Guidelines for Preoperative Preparations, Surgical Techniques, and Postoperative Care
11:06

Subretinal Implantation of RPE on a Carrier in Minipigs: Guidelines for Preoperative Preparations, Surgical Techniques, and Postoperative Care

Published on: November 11, 2022

2.8K

Related Experiment Videos

Last Updated: Jul 26, 2025

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
08:10

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

Published on: January 25, 2019

7.9K
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

3.8K
Subretinal Implantation of RPE on a Carrier in Minipigs: Guidelines for Preoperative Preparations, Surgical Techniques, and Postoperative Care
11:06

Subretinal Implantation of RPE on a Carrier in Minipigs: Guidelines for Preoperative Preparations, Surgical Techniques, and Postoperative Care

Published on: November 11, 2022

2.8K

Area of Science:

  • Ophthalmology
  • Retinal Surgery
  • Diabetic Retinopathy Treatment

Background:

  • Pars plana vitrectomy (PPV) is the primary surgical intervention for severe diabetic retinopathy.
  • Advancements in surgical technology are expanding the indications for PPV in managing diabetic retinopathy.

Purpose of the Study:

  • To review the application of new technologies in PPV for diabetic retinopathy.
  • To highlight specific procedures and challenges encountered in Asian patients with diabetic eye complications.

Main Methods:

  • Review of contemporary Pars plana vitrectomy (PPV) techniques.
  • Incorporation of collective surgical experiences, particularly with Asian patients.
  • Analysis of new technologies including microincision systems, wide-angle viewing, digital assistance, and intraoperative OCT.

Main Results:

  • Contemporary PPV is now indicated for a wider range of diabetic retinopathy complications.
  • New technologies facilitate improved visualization and surgical precision.
  • Specific procedural nuances and challenges in Asian populations were identified.

Conclusions:

  • Modern PPV techniques, aided by technological advancements, offer expanded treatment options for diabetic retinopathy.
  • Vitreoretinal surgeons can optimize approaches by understanding these new technologies and specific patient population challenges.
  • Enhanced surgical outcomes are achievable for complex diabetic eye disease.